Roster of the Digital Health Advisory Committee November 20-21, 2024: Advisory Committee Meeting

FDA plans to hold a two-day in person meeting with simultaneous webcast of the Digital Health Advisory Committee on November 20-21, 2024 in Gaithersburg, MD, to discuss total product lifecycle considerations for Generative AI-enabled devices. Topics planned to be addressed include how the use of Generative AI may impact safety and effectiveness of medical devices enabled with this technology. The FDA is seeking expert recommendations to help assess the potential risks and benefits of these devices. Further details will be provided in the Federal Register announcement that will be published in the upcoming months in accordance with FDA’s policies and procedures for Advisory Committee Meetings. https://www.fda.gov/advisory-committees/digital-health-advisory-committee/roster-digital-health-advisory-committee?utm_medium=email&utm_source=govdelivery